Literature DB >> 23990211

History of lifetime smoking, smoking cessation and cognitive function in the elderly population.

Ute Mons1, Ben Schöttker, Heiko Müller, Matthias Kliegel, Hermann Brenner.   

Abstract

To examine potential associations of the history of lifetime smoking and smoking cessation with cognitive function in the elderly. In a population-based cohort study of older adults in Saarland, Germany, a detailed lifetime history of smoking was obtained using standardised questionnaires. Cognitive function was assessed with a validated telephone-based instrument (COGTEL) at the five-year follow-up in a subsample of n = 1,697 participants with a baseline age >65 years. Multiple linear regression models were employed to predict cognitive performance, adjusting for potential confounding factors. Ever-smokers with a higher cumulative dose of smoking in pack-years scored lower in the cognitive assessment than never-smokers, with the association being more pronounced in current smokers than in former smokers. In fully adjusted models, current smokers with 21-40 pack-years scored 4.06 points lower (95 % CI -7.18 to -0.94) than never-smokers. In former smokers, a longer time since smoking cessation was associated with higher scores in the cognitive test with reference to current smokers, even after adjustment for pack-years. Former smokers who had quit for more than 30 years scored 4.23 points higher (95 % CI 1.75 to 6.71) than current smokers. Dose-response-relationships of cognitive function with cumulative dose of smoking as well as with time since smoking cessation were substantiated by restricted cubic splines regression. Our results support suggestions that smokers are at an increased risk for cognitive impairment in older age; that the risk increases with duration and intensity of smoking, and subsides with time after smoking cessation.

Entities:  

Mesh:

Year:  2013        PMID: 23990211     DOI: 10.1007/s10654-013-9840-9

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  34 in total

1.  Smoking and structural brain deficits: a volumetric MR investigation.

Authors:  Jürgen Gallinat; Eva Meisenzahl; Leslie K Jacobsen; Peter Kalus; Jeffrey Bierbrauer; Thorsten Kienast; Henning Witthaus; Karolina Leopold; Frank Seifert; Florian Schubert; Mario Staedtgen
Journal:  Eur J Neurosci       Date:  2006-09       Impact factor: 3.386

2.  Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies.

Authors:  Kaarin J Anstey; Chwee von Sanden; Agus Salim; Richard O'Kearney
Journal:  Am J Epidemiol       Date:  2007-06-14       Impact factor: 4.897

3.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

Review 4.  Life style interventions to reduce the risk of dementia.

Authors:  Leon Flicker
Journal:  Maturitas       Date:  2009-07-23       Impact factor: 4.342

5.  Measuring cognitive function with age: the influence of selection by health and survival.

Authors:  Sjoerd M Euser; Miranda T Schram; Albert Hofman; Rudi G J Westendorp; Monique M B Breteler
Journal:  Epidemiology       Date:  2008-05       Impact factor: 4.822

Review 6.  Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective?

Authors:  Francesco Panza; Vincenza Frisardi; Davide Seripa; Giancarlo Logroscino; Andrea Santamato; Bruno P Imbimbo; Emanuele Scafato; Alberto Pilotto; Vincenzo Solfrizzi
Journal:  Int J Geriatr Psychiatry       Date:  2012-03-07       Impact factor: 3.485

7.  Relationship between lifetime smoking, smoking status at older age and human cognitive function.

Authors:  Marlene C W Stewart; Ian J Deary; F Gerald R Fowkes; Jacqueline F Price
Journal:  Neuroepidemiology       Date:  2005-12-13       Impact factor: 3.282

8.  [Epidemiological investigations of the chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population (ESTHER study)].

Authors:  M Löw; C Stegmaier; H Ziegler; D Rothenbacher; H Brenner
Journal:  Dtsch Med Wochenschr       Date:  2004-12-03       Impact factor: 0.628

Review 9.  Mild cognitive impairment: a systematic review.

Authors:  Elena Mariani; Roberto Monastero; Patrizia Mecocci
Journal:  J Alzheimers Dis       Date:  2007-08       Impact factor: 4.472

10.  Changes of cardiovascular risk factors and their implications in subsequent birth cohorts of older adults in Germany: a life course approach.

Authors:  Elke Raum; Dietrich Rothenbacher; Michael Löw; Christa Stegmaier; Hartwig Ziegler; Hermann Brenner
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-12
View more
  21 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  The Generation R Study: Biobank update 2015.

Authors:  Claudia J Kruithof; Marjolein N Kooijman; Cornelia M van Duijn; Oscar H Franco; Johan C de Jongste; Caroline C W Klaver; Johan P Mackenbach; Henriëtte A Moll; Hein Raat; Edmond H H M Rings; Fernando Rivadeneira; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Eppo B Wolvius; Albert Hofman; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2014-12-21       Impact factor: 8.082

Review 3.  Pharmacological Smoking Cessation Therapies in Older Adults: A Review of the Evidence.

Authors:  Philip B Cawkwell; Caroline Blaum; Scott E Sherman
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

4.  Correlates of cognitive impairment in adult cancer survivors who have received chemotherapy and report cognitive problems.

Authors:  Shannon L Gutenkunst; Janette L Vardy; Haryana M Dhillon; Melanie L Bell
Journal:  Support Care Cancer       Date:  2020-07-14       Impact factor: 3.603

5.  Effects of cigarette smoking and alcohol use on neurocognition and BDNF levels in a Chinese population.

Authors:  Xiang Yang Zhang; Yun-Long Tan; Da-Chun Chen; Shu-Ping Tan; Fu-De Yang; Giovana B Zunta-Soares; Jair C Soares
Journal:  Psychopharmacology (Berl)       Date:  2015-10-30       Impact factor: 4.530

6.  Tobacco use is associated with reduced amplitude and intensity dependence of the cortical auditory evoked N1-P2 component.

Authors:  Philippe Jawinski; Nicole Mauche; Christine Ulke; Jue Huang; Janek Spada; Cornelia Enzenbach; Christian Sander; Ulrich Hegerl; Tilman Hensch
Journal:  Psychopharmacology (Berl)       Date:  2016-03-17       Impact factor: 4.530

Review 7.  Early origins of chronic obstructive lung diseases across the life course.

Authors:  Liesbeth Duijts; Irwin K Reiss; Guy Brusselle; Johan C de Jongste
Journal:  Eur J Epidemiol       Date:  2014-12-24       Impact factor: 8.082

8.  Current smoking is associated with worse cognitive and adaptive functioning in serious mental illness.

Authors:  C A Depp; C R Bowie; B T Mausbach; P Wolyniec; M H Thornquist; J R Luke; J A McGrath; A E Pulver; T L Patterson; P D Harvey
Journal:  Acta Psychiatr Scand       Date:  2015-01-05       Impact factor: 6.392

9.  Effects of smoking and alcohol use on neurocognitive functioning in heavy drinking, HIV-positive men who have sex with men.

Authors:  Mollie A Monnig; Christopher W Kahler; Hana Lee; David W Pantalone; Kenneth H Mayer; Ronald A Cohen; Peter M Monti
Journal:  AIDS Care       Date:  2015-10-07

10.  Relation of cigarette smoking and alcohol drinking in midlife with risk of cognitive impairment in late life: the Singapore Chinese Health Study.

Authors:  Jing Wu; Wenhong Dong; Xiong-Fei Pan; Lei Feng; Jian-Min Yuan; An Pan; Woon-Puay Koh
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.